Antibiotics for children that are covered by private insurance cost five times more in the United States than in the United Kingdom, where costs are covered by a government universal health plan. That's the finding of researchers who ...
Tags: Health, Medicine, Antibiotics
Health R&D Spending Moves Slowly Upward, Driven by Industry, Philanthropy and Voluntary Health Associations Federal R&D Funding Remains "Woefully Inadequate" to Address Health Threats and Global Competitiveness ?Highlights: ?Overall ...
After declining in FY10-11,health-related research and development(R&D)spending in the U.S.increased by$4.3 billion(3.5%)in FY11-12,according to Truth and Consequences:Health R&D Spending in the U.S.(FY11-12),the 10th edition from ...
Tags: Health R&D Spending, R&D of Health
Here are some of the latest health and medical news developments: Teens Opting for Real Pot While U.S. teens are staying away from synthetic marijuana, they're smoking more of the natural version, a new survey of more than 40,000 ...
Tags: Health, US teens, Drug Abuse, New Mosquito-Borne Virus
Pfizer Inc. announced that it has settled its litigation against Teva Pharmaceuticals, USA Inc., relating to Pfizer's patent covering the use of Viagra? to treat erectile dysfunction (sildenafil citrate 25, 50, and 100 mg tablets), which ...
Creganna-Tactx Medical has announced today that Robert B. Hance will join the company as Chief Executive Officer in September 2013, taking over the role from Helen Ryan who has held the position for the last eight years. Robert ...
Tags: medicine, Creganna-Tactx Medical
The U.S Food and Drug Administration has filed its rule on intentional adulteration under the Food Safety Modernization Act (FSMA), keeping to a court-ordered deadline of Dec. 20. "Focused Mitigation Strategies to Protect Food Against ...
Tags: Agriculture, Food
US-based privately-held therapeutic antibody firm AnaptysBio has commenced an antibody development program with Momenta Pharmaceuticals, focused on the development of new antibodies against a therapeutically relevant target. Both the ...
Boehringer Ingelheim has entered into a research collaboration agreement with and Circuit Therapeutics to discover new ways of treating psychiatric disorders. As per the deal, the companies will combine their research and development ...
Tags: Boehringer, Psychiatric Disorders
Merck Serono has signed a license agreement with the Spanish National Cancer Research Centre (CNIO) in Madrid in the area of cancer drug development and will build upon CNIO research discoveries to support the development and ...
Tags: Cancer Patients, Merck Serono
The US Food and Drug Administration (FDA) has approved GlaxoSmithKline (GSK) and Theravance's Anoro Ellipta as a once-daily, long-term maintenance treatment of airflow obstruction in patients with chronic obstructive pulmonary disease ...
The US Food and Drug Administration (FDA) and the European Medicines Agency (EMA) have announced the launch of a joint initiative to share information on inspections of bioequivalence studies submitted in support of generic drug approvals. ...
Tags: Generic Drug, Medicine
Oticon Medical, a manufacturer of bone anchored hearing systems, has obtained 510(k) approval the US Food and Drug Administration (FDA) to market its Ponto Plus bone anchored sound processors in regular version (down to a hearing loss of ...
Tags: Oticon Medical, Ponto Plus Bone
Almost half of parents concerned their child will try e-cigarettes; support high for prohibiting sale to kids, says U-M National Poll on Children's Health Adults nationwide are concerned about the use of e-cigarettes by children and ...
Tags: Health, Medicine, E-Cigarettes
Gilead Sciences has received notice of compliance from Health Canada for its once-daily oral nucleotide analog polymerase inhibitor Sovaldi or sofosbuvir 400mg tablets for the treatment of chronic hepatitis C or CHC infection. Sovaldi is ...